DBVT DBV TECHNOLOGIES SA Company Mergers 8-K Filing 2023 - Termination of Agreement DBV Technologies terminated a collaboration agreement with Nestl Health Science for the development and commercialization of MAG1C, and announced their financial results for the fiscal quarter ended September 30, 2023.Get access to all SEC 8-K filings of the DBV TECHNOLOGIES SA